These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8610514)

  • 1. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure.
    Jakobsen JA
    Acta Radiol Suppl; 1995; 399():191-5. PubMed ID: 8610514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal experience with Visipaque.
    Jakobsen JA
    Eur Radiol; 1996; 6 Suppl 2():S16-9. PubMed ID: 8798051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
    Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
    Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention.
    Zhao N; Chen Z; Zhou Y; Xu Q; Xu Z; Tong W; Li L; Mao Q; Song Y; Jin J; Huang L; Azzalini L; Zhao X
    Angiology; 2021 Feb; 72(2):145-152. PubMed ID: 32911955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.
    Nossen JO; Jakobsen JA; Kjaersgaard P; Andrew E; Jacobsen PB; Berg KJ
    Scand J Clin Lab Invest; 1995 Jul; 55(4):341-50. PubMed ID: 7569737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
    Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
    Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main results of the first comparative clinical studies on Visipaque.
    Grynne BH; Nossen JO; Bolstad B; Borch KW
    Acta Radiol Suppl; 1995; 399():265-70. PubMed ID: 8610526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
    Song T; Song M; Ge Z; Li Y; Shi P; Sun M
    J Interv Cardiol; 2017 Jun; 30(3):281-285. PubMed ID: 28421628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Lundkvist J
    Am Heart J; 2005 Feb; 149(2):298-303. PubMed ID: 15846268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
    Solomon R
    Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
    Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
    Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model.
    Cheng W; Zhao F; Tang CY; Li XW; Luo M; Duan SB
    Arch Toxicol; 2018 Jul; 92(7):2245-2257. PubMed ID: 29860548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.